Bio-Techne Announces Changes to its Leadership Team
Bio-Techne (NASDAQ:TECH) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at Wells Fargo & Company from $70.00 to $76.00. They now have an "overweight" rating on the stock.
Bio-Techne (NASDAQ:TECH) was given a new $65.00 price target on by analysts at Stifel Nicolaus.
Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at Evercore ISI from $62.00 to $68.00. They now have an "in-line" rating on the stock.